Welcome to CellCyte Genetics

CellCyte Genetics is the emerging biotechnology Company in the discovery and development of cell expansion and cell maintenance through the use of its patented bioreactor technology. The Company’s therapeutic focus is on investigative collaborations to research and develop compounds to allow the safe and efficient non-invasive delivery of stem cells through the patient’s own circulatory system to a diseased or damaged organ. Once developed and approved by the FDA, these products have the potential to change the future of regenerative medicine and stem cell therapy. For our German website, visit cellcyte.de.investorroom.com


 Email Page   Print
© Copyright 2008 CellCyte.com Disclaimer
IMPORTANT DISCLAIMER: THE INFORMATION CONTAINED IN THE COMPANY'S WEB SITE HAS BEEN PREPARED BY MANAGEMENT OF THE COMPANY WHO TAKES FULL RESPONSIBILITY FOR ITS CONTENTS.  NO SECURITIES REGULATORY AUTHORITY HAVING JURISDICTION OVER THE COMPANY OR EXCHANGE OR OVER-THE-COUNTER MARKET UPON WHICH THE COMPANY'S SECURITIES ARE PRESENTLY POSTED FOR TRADING HAS EITHER APPROVED NOR DISAPPROVED OF THE COMPANY'S WEB SITE OR THE CONTENTS OF THE INFORMATION CONTAINED IN THE COMPANY'S WEB SITE.

IN ADDITION, THE INFORMATION CONTAINED IN THE COMPANY'S WEB SITE DOES NOT, UNDER ANY CIRCUMSTANCES, CONSTITUTE A DISTRIBUTION OF ANY SECURITIES OF THE COMPANY IN ANY JURISDICTION WHATSOEVER AND SHALL NOT CONSTITUTE AN OFFER TO SELL, OR THE SOLICITATION OF AN OFFER TO BUY, ANY SECURITIES OF THE COMPANY, NOR SHALL THERE BE ANY SALE OF ANY SECURITIES OF THE COMPANY IN ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION.  FURTHERMORE, THE INFORMATION CONTAINED IN THE COMPANY'S WEB SITE IS NOT DIRECTED AT ANY PARTICULAR RESIDENTS OF ANY JURISDICTION.

THE INFORMATION CONTAINED IN THE COMPANY'S WEB SITE MAY INCLUDE 'FORWARD-LOOKING STATEMENTS', AS THAT TERM IS DEFINED IN SECTION 27A OF THE SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE SECURITIES EXCHANGE ACT OF 1934.  STATEMENTS CONTAINED IN THE COMPANY'S WEB SITE MAY INCLUDE INFORMATION WHICH IS NOT PURELY HISTORICAL, ARE FORWARD-LOOKING STATEMENTS AND INCLUDE ANY STATEMENTS REGARDING BELIEFS, PLANS, EXPECTATIONS OR INTENTIONS REGARDING THE FUTURE.  ACTUAL RESULTS COULD DIFFER FROM THOSE PROJECTED IN ANY FORWARD-LOOKING STATEMENTS DUE TO NUMEROUS FACTORS.  THESE FORWARD-LOOKING STATEMENTS ARE MADE AS OF THE DATE OF THE COMPANY'S WEB AND THE COMPANY ASSUMES NO OBLIGATION TO UPDATE THE FORWARD-LOOKING STATEMENTS, OR TO UPDATE THE REASONS WHY ACTUAL RESULTS COULD DIFFER FROM THOSE PROJECTED IN THE FORWARD-LOOKING STATEMENTS. ALTHOUGH THE COMPANY BELIEVES THAT THE BELIEFS, PLANS, EXPECTATIONS AND INTENTIONS CONTAINED IN THE COMPANY'S WEB ARE REASONABLE, THERE CAN BE NO ASSURANCE THOSE BELIEFS, PLANS, EXPECTATIONS OR INTENTIONS WILL PROVE TO BE ACCURATE.  INVESTORS SHOULD CONSIDER ALL OF THE INFORMATION SET FORTH HEREIN AND SHOULD ALSO REFER TO THE RISK FACTORS DISCLOSED IN THE COMPANY'S PERIODIC REPORTS FILED FROM TIME-TO-TIME WITH THE SECURITIES AND EXCHANGE COMMISSION.